Skip to main content
Premium Trial:

Request an Annual Quote

Orochem Snaps up Oligonet

NEW YORK (GenomeWeb News) – Reagents and sample prep products firm Orochem Technologies said today that it has acquired Oligonet, a maker of custom synthetic oligonucleotides.

Lombard, Ill.-based Orochem said it purchased Oligonet to advance its goals in the synthetic oligos market.

Orochem already offers DNA and RNA kits, as well as protein purification kits and plates to the academic, government, and industrial research markets. Oligonet, which is located in Gaithersburg, Md., provides synthetic oligodeoxynucleotides and oligonucleotides labeled with multiple modifications and dyes, Orochem said.

Financial terms of the agreement were not released.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.